Literature DB >> 30174258

The assessment, management, and reporting of falls, and the impact of falls on cancer treatment in community-dwelling older patients receiving cancer treatment: Results from a mixed-methods study.

Schroder Sattar1, Shabbir M H Alibhai2, Sandra L Spoelstra3, Martine T E Puts4.   

Abstract

BACKGROUND: Falls are major health issues among older adults and even more so in those with cancer due to cancer and its treatment. Delays in cancer treatment caused by fall injuries may have significant implications on disease trajectory and patient outcomes. However, it is not known how falls impact cancer treatment in this population.
METHODS: We conducted a convergent-parallel mixed-methods study at the Princess Margaret Cancer Centre in Toronto, Canada, to examine how falls impact cancer treatment in community-dwelling cancer patients aged ≥ 65, patients' fall reporting, and how falls were assessed and managed in oncology clinics. Data were collected by self-reported survey, chart review, and open-ended interviews.
RESULTS: One hundred older adults and fourteen oncologists participated. Falls were not commonly reported by patients to their oncologists (72 of 168 falls [43%] reported to researchers by patients were also reported to oncologists). One of fourteen oncologists routinely assessed falls. In 7% of all 72 reported falls, cancer treatment was impacted (e.g. treatment delay/cessation, dose reduction). Fifty-seven patients perceived their fall as minor incident not worth mentioning (amounted to a total of 72 falls not reported). When a participant reported their fall to the oncologist, actions were taken to assess and manage the fall. Oncologists indicated that the majority of patients were not forthcoming in reporting falls.
CONCLUSION: One in twenty who fall appear to lead to change in cancer management. However, falls were not commonly reported by patients nor prioritized by oncologists. Incorporating routine fall assessment in oncology clinic appointments may help identify those at risk for falls so that timely interventions can be triggered.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30174258     DOI: 10.1016/j.jgo.2018.08.006

Source DB:  PubMed          Journal:  J Geriatr Oncol        ISSN: 1879-4068            Impact factor:   3.599


  6 in total

1.  Oncology clinic nurses' attitudes and perceptions regarding implementation of routine fall assessment and fall risk screening: A survey study.

Authors:  Schroder Sattar; Kristen R Haase; Koen Milisen; Diane Campbell; Soo Jung Kim; Haji Chalchal; Cindy Kenis
Journal:  Can Oncol Nurs J       Date:  2021-11-01

2.  Feasibility of a Remotely Delivered Strength and Balance Training Program for Older Adults with Cancer.

Authors:  Schroder Sattar; Kristen Haase; Kelly Penz; Corrie Effa; Joni Nedeljak; Haji Chalchal; Osama Souied; Eitan Amir; Eric Pitters; Diane Campbell; Shabbir Alibhai; Margaret L McNeely
Journal:  Curr Oncol       Date:  2021-11-02       Impact factor: 3.677

3.  A survey for characterizing details of fall events experienced by lower limb prosthesis users.

Authors:  Andrew Sawers; Cody L McDonald; Brian J Hafner
Journal:  PLoS One       Date:  2022-07-28       Impact factor: 3.752

4.  Falls in older adults with cancer: an updated systematic review of prevalence, injurious falls, and impact on cancer treatment.

Authors:  T M Wildes; S Alibhai; S Sattar; K Haase; S Kuster; M Puts; S Spoelstra; C Bradley
Journal:  Support Care Cancer       Date:  2020-07-16       Impact factor: 3.603

5.  Evaluation of Fall and Fracture Risk Among Men With Prostate Cancer Treated With Androgen Receptor Inhibitors: A Systematic Review and Meta-analysis.

Authors:  Zin W Myint; Harry D Momo; Danielle E Otto; Donglin Yan; Peng Wang; Jill M Kolesar
Journal:  JAMA Netw Open       Date:  2020-11-02

Review 6.  Functional Decline in the Cancer Patient: A Review.

Authors:  Jaidyn Muhandiramge; Suzanne G Orchard; Erica T Warner; Gijsberta J van Londen; John R Zalcberg
Journal:  Cancers (Basel)       Date:  2022-03-08       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.